Upstream Bio, Inc.
UPB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Revenue | $2 | $2 | $1 |
| % Growth | -0.4% | 96.4% | – |
| Cost of Goods Sold | $0 | $0 | $0 |
| Gross Profit | $2 | $2 | $1 |
| % Margin | 100% | 100% | 100% |
| R&D Expenses | $63 | $32 | $19 |
| G&A Expenses | $17 | $11 | $6 |
| SG&A Expenses | $17 | $11 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 |
| Operating Expenses | $80 | $42 | $25 |
| Operating Income | -$78 | -$40 | -$24 |
| % Margin | -3,281.2% | -1,685.5% | -1,972.7% |
| Other Income/Exp. Net | $15 | $20 | $0 |
| Pre-Tax Income | -$63 | -$21 | -$24 |
| Tax Expense | $0 | $0 | $0 |
| Net Income | -$63 | -$21 | -$24 |
| % Margin | -2,650% | -862.9% | -1,969.3% |
| EPS | -1.49 | -1.05 | -0.66 |
| % Growth | -41.9% | -59.1% | – |
| EPS Diluted | -1.49 | -1.05 | -0.66 |
| Weighted Avg Shares Out | 51 | 36 | 36 |
| Weighted Avg Shares Out Dil | 51 | 36 | 36 |
| Supplemental Information | – | – | – |
| Interest Income | $12 | $4 | $0 |
| Interest Expense | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 |
| EBITDA | -$78 | -$40 | -$24 |
| % Margin | -3,277.4% | -1,682.9% | -1,972.1% |